New quinoline-based antiviral shows strong promise against SARS-CoV-2 Post author:admin Post published:April 10, 2025 Post category:uncategorized Post comments:0 Comments Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro). You Might Also Like NIAID scientists discover probiotic treatment for eczema June 26, 2024 Ohio State Wexner Medical Center wins $14 million award for aspirin dose study November 28, 2023 Smoking during pregnancy affects children’s academic achievement August 30, 2024 Leave a Reply Cancel replyYou must be logged in to post a comment.